Valeant gives Pershing Square a seat on its board

(Reuters) - Valeant Pharmaceuticals International Inc (NYSE: VRX) (NYSE: VRX), under scrutiny for its accounting and business practices, said it had given shareholder Pershing Square Capital Management a seat on its board and added two additional directors.

Stephen Fraidin, a veteran Wall Street lawyer who is vice chairman at William Ackman's Pershing Square, has joined the board, along with Fred Eshelman and Thomas Ross, Valeant said.

Anders Lonner has stepped down as a director, the company said on Wednesday.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• UK loses case over asylum seeker rejections linked to migrant deal with France
• SpaceX's near-term AI payoff seen tethered to Earth, not outer space
• SK Hynix options to trade two business days after Nasdaq debut, sources say